Matches in SemOpenAlex for { <https://semopenalex.org/work/W1505162105> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W1505162105 endingPage "13" @default.
- W1505162105 startingPage "3906" @default.
- W1505162105 abstract "Seven children and eight adults with CD19+ B-lineage acute lymphoblastic leukemia, as well as one adult with chronic lymphocytic leukemia, were treated with the CD19 receptor-directed tyrosine kinase inhibitor B43-Genistein. All patients had failed previous chemotherapy regimens, and six patients had relapsed after bone marrow transplantation. B43-Genistein was administered as a 1-hour i.v. infusion at 0.1-0.32 mg/kg/day dose levels for 10 consecutive days or 3 consecutive days weekly for a total of nine doses. B43-Genistein was well tolerated by all patients with no life-threatening side effects. There were six episodes of grade 2-3 fever, two of which were clearly drug related, one episode each of grade 3 myalgia, grade 2 sinus tachycardia, and grade 2 vascular leak syndrome. There was one durable complete remission and two transient responses. Pharmacokinetic analyses in 12 patients revealed a plasma half-life of 20 +/- 5 h, mean residence time of 24 +/- 5 h, and a systemic clearance rate of 20 +/- 3 ml/h/kg. Moderate levels of human antimouse antibody (HAMA) ranging from 20-87 ng/ml were detected in the day 28 blood samples from three of nine cases examined. Treatment of these three HAMA-positive patients with a second course of B43-Genistein did not yield measurable immunoconjugate levels in the plasma, indicating that the administered B43-Genistein molecules were rapidly cleared from circulation due to the HAMA. On the basis of its acceptable toxicity profile and its ability to elicit objective responses at nontoxic dose levels, B43-Genistein may provide the basis for an effective treatment strategy for B-lineage acute lymphoblastic leukemia patients who have failed standard therapy." @default.
- W1505162105 created "2016-06-24" @default.
- W1505162105 creator A5000068323 @default.
- W1505162105 creator A5020617631 @default.
- W1505162105 creator A5029825658 @default.
- W1505162105 creator A5035054224 @default.
- W1505162105 creator A5046062964 @default.
- W1505162105 creator A5047526614 @default.
- W1505162105 creator A5075850990 @default.
- W1505162105 creator A5083018211 @default.
- W1505162105 creator A5089371307 @default.
- W1505162105 date "1999-12-01" @default.
- W1505162105 modified "2023-10-17" @default.
- W1505162105 title "Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor." @default.
- W1505162105 cites W1480844331 @default.
- W1505162105 cites W1516782937 @default.
- W1505162105 cites W1656644300 @default.
- W1505162105 cites W1660960094 @default.
- W1505162105 cites W1884891985 @default.
- W1505162105 cites W1980485261 @default.
- W1505162105 cites W2030407167 @default.
- W1505162105 cites W2061755251 @default.
- W1505162105 cites W2100962723 @default.
- W1505162105 cites W2104160742 @default.
- W1505162105 cites W2112997504 @default.
- W1505162105 cites W2141534282 @default.
- W1505162105 cites W2343902749 @default.
- W1505162105 cites W303871225 @default.
- W1505162105 cites W33007984 @default.
- W1505162105 cites W53647604 @default.
- W1505162105 cites W69385394 @default.
- W1505162105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10632319" @default.
- W1505162105 hasPublicationYear "1999" @default.
- W1505162105 type Work @default.
- W1505162105 sameAs 1505162105 @default.
- W1505162105 citedByCount "24" @default.
- W1505162105 countsByYear W15051621052012 @default.
- W1505162105 countsByYear W15051621052013 @default.
- W1505162105 countsByYear W15051621052015 @default.
- W1505162105 countsByYear W15051621052017 @default.
- W1505162105 countsByYear W15051621052023 @default.
- W1505162105 crossrefType "journal-article" @default.
- W1505162105 hasAuthorship W1505162105A5000068323 @default.
- W1505162105 hasAuthorship W1505162105A5020617631 @default.
- W1505162105 hasAuthorship W1505162105A5029825658 @default.
- W1505162105 hasAuthorship W1505162105A5035054224 @default.
- W1505162105 hasAuthorship W1505162105A5046062964 @default.
- W1505162105 hasAuthorship W1505162105A5047526614 @default.
- W1505162105 hasAuthorship W1505162105A5075850990 @default.
- W1505162105 hasAuthorship W1505162105A5083018211 @default.
- W1505162105 hasAuthorship W1505162105A5089371307 @default.
- W1505162105 hasConcept C112705442 @default.
- W1505162105 hasConcept C121608353 @default.
- W1505162105 hasConcept C126322002 @default.
- W1505162105 hasConcept C22979827 @default.
- W1505162105 hasConcept C2778461978 @default.
- W1505162105 hasConcept C2778820342 @default.
- W1505162105 hasConcept C2781107101 @default.
- W1505162105 hasConcept C2909962599 @default.
- W1505162105 hasConcept C29730261 @default.
- W1505162105 hasConcept C71924100 @default.
- W1505162105 hasConcept C90924648 @default.
- W1505162105 hasConcept C98274493 @default.
- W1505162105 hasConceptScore W1505162105C112705442 @default.
- W1505162105 hasConceptScore W1505162105C121608353 @default.
- W1505162105 hasConceptScore W1505162105C126322002 @default.
- W1505162105 hasConceptScore W1505162105C22979827 @default.
- W1505162105 hasConceptScore W1505162105C2778461978 @default.
- W1505162105 hasConceptScore W1505162105C2778820342 @default.
- W1505162105 hasConceptScore W1505162105C2781107101 @default.
- W1505162105 hasConceptScore W1505162105C2909962599 @default.
- W1505162105 hasConceptScore W1505162105C29730261 @default.
- W1505162105 hasConceptScore W1505162105C71924100 @default.
- W1505162105 hasConceptScore W1505162105C90924648 @default.
- W1505162105 hasConceptScore W1505162105C98274493 @default.
- W1505162105 hasIssue "12" @default.
- W1505162105 hasLocation W15051621051 @default.
- W1505162105 hasOpenAccess W1505162105 @default.
- W1505162105 hasPrimaryLocation W15051621051 @default.
- W1505162105 hasRelatedWork W1967512152 @default.
- W1505162105 hasRelatedWork W1971898273 @default.
- W1505162105 hasRelatedWork W2110229208 @default.
- W1505162105 hasRelatedWork W2144299645 @default.
- W1505162105 hasRelatedWork W2146102943 @default.
- W1505162105 hasRelatedWork W2168337309 @default.
- W1505162105 hasRelatedWork W2607418785 @default.
- W1505162105 hasRelatedWork W3130514033 @default.
- W1505162105 hasRelatedWork W3215054922 @default.
- W1505162105 hasRelatedWork W4200153820 @default.
- W1505162105 hasVolume "5" @default.
- W1505162105 isParatext "false" @default.
- W1505162105 isRetracted "false" @default.
- W1505162105 magId "1505162105" @default.
- W1505162105 workType "article" @default.